Vident Investment Advisory, LLC Exelixis, Inc. Transaction History

Vident Investment Advisory, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $43,211 - $51,455	2,651 Added 19.68%	16,124 $312,000
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $1.54 Million - $1.79 Million	-102,974 Reduced 88.43%	13,473 $216,000
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $1.83 Million - $2.59 Million	116,447 New	116,447 $1.77 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $287,106 - $374,196	-13,890 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$16.46 - $27.42 $228,629 - $380,863	13,890 New	13,890 $330,000
Q2 2019 Aug 12, 2019	SELL	$18.93 - $24.75 $294,645 - $385,233	-15,565 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$19.6 - $24.76 $154,330 - $194,960	-7,874 Reduced 33.59%	15,565 $370,000
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $20,720 - $33,092	-1,518 Reduced 6.08%	23,439 $461,000
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $8,030 - $11,334	-506 Reduced 1.99%	24,957 $442,000
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $111,916 - $135,373	6,030 Added 31.03%	25,463 $548,000
Q1 2018 May 14, 2018	SELL	$22.15 - $31.89 $85,299 - $122,808	-3,851 Reduced 16.54%	19,433 $396,000
Q4 2017 Feb 15, 2018	SELL	$24.23 - $30.93 $218,845 - $279,359	-9,032 Reduced 27.95%	23,284 $708,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $754,578 - $944,919	32,316	32,316 $783,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.